The scary foreign policy implications of Trump's COVID-19 diagnosis
As of Friday morning, President Trump's COVID-19 symptoms are reportedly mild and Vice President Mike Pence has tested negative for the virus. But if things take a turn for the worse in the White House, with House Speaker (and Democrat) Nancy Pelosi next in line of succession, things could get scary very quickly — and nowhere more so than in foreign policy.
The greatest danger would be the possibility of foreign powers taking advantage of the domestic chaos embroiling the senior leadership of the country to make bold moves on the world stage, perhaps in coordination. Imagine Vladimir Putin making a deeper incursion into Ukraine or attempting to seize one of the Baltic states (probably Lithuania) — while China, in the boldest and riskiest act of all, makes a move against Taiwan.
One or both of these scenarios are likely in the coming decade, as rising or defiant powers seek to test American resolve in attempting to uphold the liberal international order. But a succession crisis would present a unique opportunity to undertake the test ahead of schedule, at a moment when the United States is maximally distracted.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Of course our internal confusion wouldn't guarantee that the U.S. would let the provocation(s) stand. On the contrary, one could imagine a scenario in which some combination of Secretary of State Mike Pompeo, Secretary of Defense Mark Esper, and the Joint Chiefs of Staff bypass a sidelined West Wing to mount a military response.
Would this be a responsible act of bold statesmanship by unelected officials? Or a military coup? Two weeks ago, it seemed we were already living through interesting times. Two weeks from now, we could learn that we hadn't seen anything yet.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Damon Linker is a senior correspondent at TheWeek.com. He is also a former contributing editor at The New Republic and the author of The Theocons and The Religious Test.
-
Will California's EV mandate survive Trump, SCOTUS challenge?
Today's Big Question The Golden State's climate goal faces big obstacles
By Joel Mathis, The Week US Published
-
'Underneath the noise, however, there’s an existential crisis'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
2024: the year of distrust in science
In the Spotlight Science and politics do not seem to mix
By Devika Rao, The Week US Published
-
Should we be worried about declining birth rates?
Talking Points Baby boom or bust
By Devika Rao, The Week US Published
-
Are men the problem with male contraception?
Talking Points Science could now offer contraceptive gels and pills for men, but questions remain over trials, and men's responsibility
By Chas Newkey-Burden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
The bird flu fight is faltering
Talking Points Are pandemic lessons going unheeded?
By Joel Mathis, The Week US Published
-
OTC birth control arrives amid the battle over reproductive rights
Talking Points Opill will cost $19.99 a month. Democrats are pushing to make it cheaper.
By Joel Mathis, The Week US Published
-
What Florida is — and isn't — doing to curb the biggest measles outbreak in the US
Talking Points DeSantis appointee defies expert consensus to stop the spread
By Joel Mathis, The Week US Published
-
Covid inquiry: the most important questions for Boris Johnson
Talking Point Former PM has faced weeks of heavy criticism from former colleagues at the public hearing
By The Week Staff Published
-
No, it's not over
Talking Point New Omicron subvariants are headed our way
By William Falk Published